Real Stories Of Americans Who Will Be Affected By The Proposed Changes To The ACA — And What YOU Can Do To Fight
With the proposed changes to the Affordable Care Act (ACA), 20 million Americans are at risk of losing their health care coverage. A survey, conducted by Brunswick Partners, found that “75 percent of Americans agree that the proposed changes to Medicaid in the AHCA are a bad idea. And that we should not allow 14 million Americans to become uninsured even if there is a potential to reduce Medicaid spending. These results are significant because they find majorities of Americans identifying as conservatives (55 percent), moderates (82 percent) and liberals (90 percent) are opposed to the AHCA’s Medicaid provisions.” Some of the proposed changes to the ACA made by the House include: Over $800 Billion in cuts to Medicaid* Elimination of the Medicaid expansion* Reversal of the pre-existing conditions clause Elimination of many of the essential health benefits (EHB) Cuts to behavioral and mental health coverage Raises in premiums for those over 65 30% surcharge for those who don’t have coverage in order to get coverage Eliminates Federal subsidies and replaces them with tax credits based on age Elimination of many of the workforce diversity provisions Inclusion of high-risk pools Shift to per capita caps and block grants Elimination of women’s healthcare coverage Lifetime caps *These Medicaid cuts and caps are not at all related to the ACA, but are only there to “pay for” for the tax breaks for the wealthy ...
Effect of polyvalent immunoglobulins on the cytokine cascade in monocytes from colorectal cancer patients: Basis for a new adjuvant therapy . Int J Clin Pharmacol Ther. 2017 Dec 12;: Authors: Gasser M, Lissner R, Waaga-Gasser AM PMID: 29231166 [PubMed - as supplied by publisher]
CONCLUSION: This case report demonstrates the satisfactory control of Sjogren's syndrome using oral polyvalent immunoglobulins with vitamin D3. In contrast to treatment options involving antimalarial drugs and methotrexate, there are no safety issues in patients tolerant to milk products. . PMID: 29231165 [PubMed - as supplied by publisher]
CONCLUSION: The results suggest that the combination of lapatinib plus capecitabine can improve PFS and OS in patients with HER2-positive breast cancer that has progressed on trastuzumab. However, it appears that trastuzumab emtansine provides better treatment outcomes in this context. . PMID: 29231164 [PubMed - as supplied by publisher]
Linda van Eikenhorst, Katja Taxis, Liset van Dijk, Han de Gier
Conclusion: The overall melanoma detection rate in our free Skin Cancer Screening Program is comparable to those in European public activities. The costs of free screening programs compare favorably with the prevented potential therapeutic costs of late-stage melanoma. The low response rate of screenees agreeing to be followed up limits conclusions of this study.Dermatology
This study aimed to assess the effects of ZST93 on cell proliferation and its role in the chemosensitivity to gemcitabine in human pancreatic cancer cells. The effects of ZST93 on cancer cell proliferation, cell cycle distribution, apoptosis and autophagy were evaluated in various human pancreatic cancer cell lines, and the anti‐tumor effects of ZST93 alone and in combination with gemcitabine were identified in a xenograft mouse model. The results showed that ZST93 could inhibit the proliferation of pancreatic cancer cells and arrest cell cycle at G0/G1 phase by regulating the expression of Cyclin D1 and Cyclin A2. Moreo...
Date: Friday, 12 15, 2017; Speaker: Hideho Okada, M.D., Ph.D., Professor Director, Brain Tumor Immunotherapy Center, University of California San Francisco; Building: Building 10 (Clinical Center); Lipsett Amphitheater; CME Credit; Videocast Event
Date: Tuesday, 04 03, 2018; Speaker: Paul Bieniasz, Rockefeller University; Gordon Carmichael, University of Connecticut; Mariano Garcia-Blanco, University of Texas; Eva Gottwein, Northwestern University; Wei-Shau Hu, National Cancer Institute; Jianming Hu, Pennsylvania State University; Rozanne Sandri-Goldin, University of California, Irvine; Building: Building 45 (Natcher Building); E1/E2
Date: Monday, 04 09, 2018; Speaker: Bruno Amati, European Institute of Oncology; Jay Bradner, Novartis; Michael Cole, Dartmouth College; Chi Van Dang, Ludwig Institute for Cancer Research; Martin Eilers, University of Wurzburg; Robert Eisenman, Fred Hutch Cancer Research Center; Gerard Evan, Cambridge University; Dean Felsher, Stanford University; Carla Grandori, Cure First; Ross Hannon, John Curtin School of Medical Research; Marie Arsenian Henriksson, Karolinska Institutet; Laurence Hurley, University of Arizona; Raghu Kalluri, MD Anderson Cancer Center; Angela Koehler, Massachusetts Institute of Technology; Linda Penn, ...
Saheli Sarkar, Pooja Sabhachandani, Dashnamoorthy Ravi, Sayalee Potdar, Sneha Purvey, Afshin Beheshti, Andrew M. Evens, Tania Konry
More News: Accidents | Acute Leukemia | Acute Myeloid Leukemia | Addiction | American Health | Anemia | Atresia | Autoimmune Disease | Blindness | Blood Transusion | Boys | Brain | Brain Cancers | Breast Cancer | Budgets | Cancer | Cancer & Oncology | Cerebral Palsy | Child Abuse | Childhood Cancer | Children | Chronic Leukemia | Diabetes | Diabetes Type 1 | Disability | Endocrinology | Epilepsy | Esophageal Atresia | Esophagus Cancer | Eyes | Gastroenteritis | Gastroenterology | Gastroschisis Repair | Girls | Glaucoma | Grants | Health Insurance | Health Management | Hospitals | Insulin | Insurance | Insurers | Jobs | Legislation | Leukemia | Lung Transplant | Lymphoma | Medicaid | Medicare | Men | Neurology | Nightmares | Nurses | Nursing | Occupational Health | Opthalmology | Pediatrics | Perinatology & Neonatology | PET Scan | Podcasts | Politics | Post Traumatic Stress Disorder | Sexual Abuse | Sickle Cell Anemia | Sleep Disorders | Sleep Medicine | Texas University | Tracheal Cancer | Tracheo-Esophageal Fistula | Transplant Surgery | Transplants | Uninsured | Websites | Women